ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Northwestern’s Lurie Center Wins NCI Support Grants

December 10, 1993

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004